247 related articles for article (PubMed ID: 29410320)
1. A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.
Moreno P; Mantey SA; Lee SH; Ramos-Álvarez I; Moody TW; Jensen RT
Peptides; 2018 Mar; 101():213-226. PubMed ID: 29410320
[TBL] [Abstract][Full Text] [Related]
2. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers.
Sun B; Schally AV; Halmos G
Regul Pept; 2000 Jun; 90(1-3):77-84. PubMed ID: 10828496
[TBL] [Abstract][Full Text] [Related]
3. ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.
Moody TW; Mantey SA; Moreno P; Nakamura T; Lacivita E; Leopoldo M; Jensen RT
Peptides; 2015 Feb; 64():55-61. PubMed ID: 25554218
[TBL] [Abstract][Full Text] [Related]
4. Bombesin receptor structure and expression in human lung carcinoma cell lines.
Fathi Z; Way JW; Corjay MH; Viallet J; Sausville EA; Battey JF
J Cell Biochem Suppl; 1996; 24():237-46. PubMed ID: 8806106
[TBL] [Abstract][Full Text] [Related]
5. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
Siegfried JM; Krishnamachary N; Gaither Davis A; Gubish C; Hunt JD; Shriver SP
Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
[TBL] [Abstract][Full Text] [Related]
6. Bombesin-like peptide receptor gene expression, regulation, and function in fetal murine lung.
Shan L; Emanuel RL; Dewald D; Torday JS; Asokanathan N; Wada K; Wada E; Sunday ME
Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L165-73. PubMed ID: 12959933
[TBL] [Abstract][Full Text] [Related]
7. Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells.
DeMichele MA; Davis AL; Hunt JD; Landreneau RJ; Siegfried JM
Am J Respir Cell Mol Biol; 1994 Jul; 11(1):66-74. PubMed ID: 8018339
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism.
Lee L; Ramos-Alvarez I; Moody TW; Mantey SA; Jensen RT
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118625. PubMed ID: 31862538
[TBL] [Abstract][Full Text] [Related]
9. Development and Characterization of a Novel, High-Affinity, Specific, Radiolabeled Ligand for BRS-3 Receptors.
Ramos-Alvarez I; Lee L; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 2019 Jun; 369(3):454-465. PubMed ID: 30971479
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.
Chatzistamou I; Schally AV; Szepeshazi K; Groot K; Hebert F; Arencibia JM
Cancer Lett; 2001 Sep; 171(1):37-45. PubMed ID: 11485826
[TBL] [Abstract][Full Text] [Related]
12. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
[TBL] [Abstract][Full Text] [Related]
13. Novel chiral-diazepines function as specific, selective receptor agonists with variable coupling and species variability in human, mouse and rat BRS-3 receptor cells.
Ramos-Álvarez I; Nakamura T; Mantey SA; Moreno P; Nuche-Berenguer B; Jensen RT
Peptides; 2016 Jan; 75():8-17. PubMed ID: 26524625
[TBL] [Abstract][Full Text] [Related]
14. Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers.
Sun B; Halmos G; Schally AV; Wang X; Martinez M
Prostate; 2000 Mar; 42(4):295-303. PubMed ID: 10679759
[TBL] [Abstract][Full Text] [Related]
15. Activation of bombesin receptor subtype-3 stimulates adhesion of lung cancer cells.
Hou X; Wei L; Harada A; Tatamoto K
Lung Cancer; 2006 Nov; 54(2):143-8. PubMed ID: 16979789
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells.
Toi-Scott M; Jones CL; Kane MA
Lung Cancer; 1996 Nov; 15(3):341-54. PubMed ID: 8959679
[TBL] [Abstract][Full Text] [Related]
17. Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells.
Thomas SM; Grandis JR; Wentzel AL; Gooding WE; Lui VW; Siegfried JM
Neoplasia; 2005 Apr; 7(4):426-31. PubMed ID: 15967120
[TBL] [Abstract][Full Text] [Related]
18. A selective human bombesin receptor subtype-3 peptide agonist mediates CREB phosphorylation and transactivation.
Qin X; Qu X; Coy D; Weber HC
J Mol Neurosci; 2012 Jan; 46(1):88-99. PubMed ID: 22127929
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor.
González N; Nakagawa T; Mantey SA; Sancho V; Uehara H; Katsuno T; Jensen RT
J Pharmacol Exp Ther; 2009 Oct; 331(1):265-76. PubMed ID: 19628633
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide.
Tokita K; Hocart SJ; Coy DH; Jensen RT
Mol Pharmacol; 2002 Jun; 61(6):1435-43. PubMed ID: 12021405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
